Weihu Wang
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 64
- Colorectal Cancer Surgical Treatments 32
- Viral-associated cancers and disorders 12
-
- Lymphoma Diagnosis and Treatment 36
- Co-authors
- Ye‐Xiong Li (96 shared papers)Shulian Wang (82 shared papers)Yue‐Ping Liu (39 shared papers)Zihao Yu (37 shared papers)Jing Jin (31 shared papers)Xin-Fan Liu (39 shared papers)Hui Fang (55 shared papers)Yong-Wen Song (30 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (19 papers)Frontiers in Oncology (8 papers)BMC Cancer (7 papers)Radiotherapy and Oncology (5 papers)Annals of Hematology (5 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Weihu Wang
198 papers receiving 3.6k citations
Weihu Wang's Hit Papers
Peers
Comparison fields: 5 of 126
- Pathology and Forensic Medicine 1.2k
- Hepatology 445
- Oncology 1.2k
- Cancer Research 282
- Immunology 334
Countries citing papers authored by Weihu Wang
This map shows the geographic impact of Weihu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihu Wang more than expected).
Fields of papers citing papers by Weihu Wang
This network shows the impact of papers produced by Weihu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihu Wang. The network helps show where Weihu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weihu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 307 | |
| 2 | 2017 | 171 | |
| 3 | 2022 | 100 | |
| 4 | 2020 | 98 | |
| 5 | 2012 | 96 | |
| 6 | 2009 | 94 | |
| 7 | 2008 | 91 | |
| 8 | 2017 | 91 | |
| 9 | 2011 | 79 | |
| 10 | 2009 | 74 | |
| 11 | Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China Hit paper breakdown → | 2024 | 63 |
| 12 | 2021 | 62 | |
| 13 | 2021 | 58 | |
| 14 | 2011 | 58 | |
| 15 | 2015 | 57 | |
| 16 | 2013 | 54 | |
| 17 | 2011 | 53 | |
| 18 | 2013 | 53 | |
| 19 | 2020 | 52 | |
| 20 | 2021 | 51 |
About Weihu Wang
Weihu Wang is a scholar working on Oncology, Pathology and Forensic Medicine, Hepatology, Radiation and Cancer Research, having authored 216 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (36 papers), Colorectal Cancer Surgical Treatments (32 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Advanced Radiotherapy Techniques (16 papers), Breast Cancer Treatment Studies (16 papers), Colorectal and Anal Carcinomas (13 papers), Gastric Cancer Management and Outcomes (12 papers) and Viral-associated cancers and disorders (12 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Hepatology (445 citations), Oncology (1.2k citations), Cancer Research (282 citations) and Immunology (334 citations). Weihu Wang has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Ye‐Xiong Li, Shulian Wang, Yue‐Ping Liu, Zihao Yu, Jing Jin, Xin-Fan Liu, Hui Fang, Yong-Wen Song, Liqiang Zhou and Yueping Liu. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Frontiers in Oncology, BMC Cancer, Radiotherapy and Oncology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.